Moonlake Immunotherapeutics Stock Total Asset
| MLTX Stock | USD 40.85 0.89 2.23% |
MoonLake Immunotherapeutics fundamentals help investors to digest information that contributes to MoonLake Immunotherapeuti's financial success or failures. It also enables traders to predict the movement of MoonLake Stock. The fundamental analysis module provides a way to measure MoonLake Immunotherapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MoonLake Immunotherapeuti stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 526.5 M | 552.9 M | |
| Intangibles To Total Assets | 0.00 | 0.00 |
MoonLake | Total Asset |
MoonLake Immunotherapeutics Company Total Asset Analysis
MoonLake Immunotherapeuti's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current MoonLake Immunotherapeuti Total Asset | 526.54 M |
Most of MoonLake Immunotherapeuti's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MoonLake Immunotherapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MoonLake Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for MoonLake Immunotherapeuti is extremely important. It helps to project a fair market value of MoonLake Stock properly, considering its historical fundamentals such as Total Asset. Since MoonLake Immunotherapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MoonLake Immunotherapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MoonLake Immunotherapeuti's interrelated accounts and indicators.
Click cells to compare fundamentals
MoonLake Total Asset Historical Pattern
Today, most investors in MoonLake Immunotherapeuti Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MoonLake Immunotherapeuti's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of MoonLake Immunotherapeuti total asset as a starting point in their analysis.
MoonLake Immunotherapeuti Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
MoonLake Total Assets
Total Assets |
|
Based on the latest financial disclosure, MoonLake Immunotherapeutics has a Total Asset of 526.54 M. This is 93.0% lower than that of the Biotechnology sector and 73.35% lower than that of the Health Care industry. The total asset for all United States stocks is 98.21% higher than that of the company.
MoonLake Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MoonLake Immunotherapeuti's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MoonLake Immunotherapeuti could also be used in its relative valuation, which is a method of valuing MoonLake Immunotherapeuti by comparing valuation metrics of similar companies.MoonLake Immunotherapeuti is currently under evaluation in total asset category among related companies.
MoonLake Immunotherapeuti ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, MoonLake Immunotherapeuti's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to MoonLake Immunotherapeuti's managers, analysts, and investors.Environmental | Governance | Social |
MoonLake Immunotherapeuti Institutional Holders
Institutional Holdings refers to the ownership stake in MoonLake Immunotherapeuti that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of MoonLake Immunotherapeuti's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing MoonLake Immunotherapeuti's value.| Shares | Westfield Capital Management Company, Lp | 2024-03-31 | 910.9 K | Polar Capital Holdings Plc | 2024-03-31 | 858 K | Fred Alger Management, Llc | 2024-03-31 | 666.7 K | Marshall Wace Asset Management Ltd | 2024-03-31 | 510.9 K | Pictet Asset Manangement Sa | 2024-03-31 | 499.8 K | Balyasny Asset Management Llc | 2024-03-31 | 424.7 K | Blackrock Inc | 2023-12-31 | 381.7 K | Finepoint Capital Lp | 2024-03-31 | 360.9 K | Perceptive Advisors Llc | 2024-03-31 | 339 K | Bvf Inc | 2024-03-31 | 21.8 M | Cormorant Asset Management, Llc | 2024-03-31 | 8.5 M |
MoonLake Fundamentals
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.12 | ||||
| Current Valuation | 2.03 B | ||||
| Shares Outstanding | 62.87 M | ||||
| Shares Owned By Insiders | 15.27 % | ||||
| Shares Owned By Institutions | 97.10 % | ||||
| Number Of Shares Shorted | 7.28 M | ||||
| Price To Book | 5.56 X | ||||
| EBITDA | (54.11 M) | ||||
| Net Income | (36.01 M) | ||||
| Cash And Equivalents | 92.71 M | ||||
| Cash Per Share | 2.51 X | ||||
| Total Debt | 3.7 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 25.51 X | ||||
| Book Value Per Share | 8.63 X | ||||
| Cash Flow From Operations | (42.78 M) | ||||
| Short Ratio | 19.60 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 70.93 | ||||
| Number Of Employees | 50 | ||||
| Beta | 1.19 | ||||
| Market Capitalization | 2.57 B | ||||
| Total Asset | 526.54 M | ||||
| Retained Earnings | (116.66 M) | ||||
| Working Capital | 504.2 M | ||||
| Net Asset | 526.54 M |
About MoonLake Immunotherapeuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MoonLake Immunotherapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MoonLake Immunotherapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MoonLake Immunotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MoonLake Immunotherapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MoonLake Immunotherapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moonlake Immunotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moonlake Immunotherapeutics Stock:Check out MoonLake Immunotherapeuti Piotroski F Score and MoonLake Immunotherapeuti Altman Z Score analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for MoonLake Stock analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is MoonLake Immunotherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MoonLake Immunotherapeuti. If investors know MoonLake will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MoonLake Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Return On Assets (0.12) | Return On Equity (0.15) |
The market value of MoonLake Immunotherapeuti is measured differently than its book value, which is the value of MoonLake that is recorded on the company's balance sheet. Investors also form their own opinion of MoonLake Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is MoonLake Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MoonLake Immunotherapeuti's market value can be influenced by many factors that don't directly affect MoonLake Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MoonLake Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if MoonLake Immunotherapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MoonLake Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.